Standard Standard

From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. / Hughes, D.; Hughes, D.A.
2002. Paper presented at International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA.

Research output: Contribution to conferencePaper

HarvardHarvard

Hughes, D & Hughes, DA 2002, 'From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics', Paper presented at International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA, 3/01/01.

APA

Hughes, D., & Hughes, D. A. (2002). From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. Paper presented at International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA.

CBE

Hughes D, Hughes DA. 2002. From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. Paper presented at International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA.

MLA

Hughes, D. and D.A. Hughes From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA, 03 Jan 0001, Paper, 2002.

VancouverVancouver

Hughes D, Hughes DA. From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. 2002. Paper presented at International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA.

Author

Hughes, D. ; Hughes, D.A. / From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics. Paper presented at International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA.

RIS

TY - CONF

T1 - From efficacy to cost-effectiveness: accounting for non-compliance in pharmacoeconomics

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2002/5/1

Y1 - 2002/5/1

M3 - Paper

T2 - International Society for Pharmacoeconomics and Outcomes Reesearch, Washington DC, USA

Y2 - 3 January 0001

ER -